HS-10587 / Jiangsu Hansoh Pharma - LARVOL DELTA

A Study of HS-10587 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=362 | Not yet recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.

New P1 trial • Oncology • Solid Tumor • MTAP

Hansoh Pharmaceutical Group…is pleased to announce that, HS-10587 tablets…has obtained the Clinical Trial Approval issued by the National Medical Products Administration (NMPA) of China, which is intended to be investigated in clinical trials for MTAP- deleted advanced solid tumors (HKEXnews)

New trial • Solid Tumor